^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Glioma |
| Drug: | Avastin (bevacizumab) (VEGF-A inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Anaplastic Glioma...Other Recommended Regimens...Carmustine or lomustine + bevacizumab...TMZ + bevacizumab.
Secondary therapy:
carmustine; temozolomide; lomustine
